Canada Markets open in 8 hrs 40 mins

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
38.47+0.31 (+0.81%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close38.16
Open38.41
Bid38.39 x 1400
Ask38.56 x 3200
Day's Range38.21 - 38.66
52 Week Range31.43 - 48.25
Volume3,100,857
Avg. Volume4,980,891
Market Cap97.284B
Beta (5Y Monthly)0.32
PE Ratio (TTM)38.78
EPS (TTM)0.99
Earnings DateFeb. 01, 2017 - Feb. 06, 2017
Forward Dividend & Yield2.03 (5.27%)
Ex-Dividend DateNov. 12, 2020
1y Target Est48.50
  • Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy
    Zacks

    Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy

    Vir Biotechnology (VIR) and its British partner, Glaxo announces agreement umder which they will evaluate their second coronavirus therapeutic candidate.

  • The 50 best places to work in the UK in 2021
    Yahoo Finance UK

    The 50 best places to work in the UK in 2021

    Glassdoor’s Employees’ Choice Awards features a list of business across a range of sectors, including finance, manufacturing, pharmaceuticals, insurance, technology and food.

  • Why Vir Biotechnology Stock Vaulted Higher Today
    Motley Fool

    Why Vir Biotechnology Stock Vaulted Higher Today

    Shares of Vir Biotechnology (NASDAQ: VIR) were vaulting 12.8% higher as of 3:07 p.m. EST on Tuesday. The big jump came after the company announced news about separate collaborations with Gilead Sciences (NASDAQ: GILD) and GlaxoSmithKline (NYSE: GSK). Vir and Gilead plan to work together on a phase 2 study evaluating Vir's VIR-2218 with Gilead's selgantolimod in treating individuals infected with the hepatitis B virus (HBV).